Kynam Capital Management, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Celldex Therapeutics, Inc. Common Stock, par value $0.001 (CLDX)

Filing Manager: Kynam Capital Management, LP
Reporting Manager: Kynam Capital Management, LP
Security: Celldex Therapeutics, Inc. Common Stock, par value $0.001
Symbol: CLDX
Shares outstanding: 66.4M shares
Disclosed Ownership: 5.06M shares
Ownership: 7.63%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 17:16:09 UTC
Date of event: 31 Dec 2024
Next filing: 15 May 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Kynam Capital Management, LP	7.63%	5.06M	0	5.06M	Yue Tang	Managing Member
Kynam Capital Management GP, LLC	7.63%	5.06M	0	5.06M	Yue Tang	Managing Member
Yue Tang	7.63%	5.06M	0	5.06M	Yue Tang	Self